Master document for setting up and running the men's health clinic at DoctoriumGP. Clinical tiers, market data, persona research, acquisition channels (Companies House + warm partnerships), tax-efficient corporate B2B, costs, revenue, 30/90/365 action plan, risk register. The premium-revenue side of the business. The men's clinical funnel that the mobile programmes feed into.
Market is real and reachable. 5,000-7,500 wealthy men aged 45-65 within 45 minutes of Derby (sourced: ONS postcode-level income data, HMRC personal income statistics, Knight Frank Wealth Report). 2,000-2,800 owner-managed companies in the £2-10m turnover band — the bullseye target segment. PMI penetration 70-85% — pre-qualified buyers.
East Midlands premium-but-attainable band confirmed. Defensible price ladder: Foundations £1,495 / Optimise £2,995 / Optimise+ £4,999. Sits below London tier (HUM2N £6k+, HOOKE £21-54k/yr) and above commodity tier (Bluecrest £179-339, Numan £40-100/mo). Regent Street Clinic Derby SUPERSCREEN at £2,995 is the local premium ceiling we anchor against.
The killer commercial wedge. HMRC EIM21765 lets companies pay one annual screen + medical with zero benefit-in-kind tax. Combined with corporation tax relief, the corporate route is 2.2× more efficient than personal-pay. The director is buyer AND recipient. 53% of UK SMEs would cease trading within 12 months if a key person was lost (L&G data) — the case for the corporate B2B / key-worker package.
Underserved male segment in adjacent markets. Only 22% of UK GLP-1 patients are male (Health Foundation × Voy 113,630 patient analysis). Male share of UK aesthetics is 21% and growing +26% YoY (BAAPS 2024). Male HBOT for ED-post-prostatectomy has clinical evidence (Hadanny 2018) and zero East Midlands competitor.
Year 3 ARR target for men's clinical line: £800k-£1.5m. Conservative path. Realistic with proper acquisition.
All sourced from competitive pricing scan and persona research (Reports 02 + 05). Margins from Stride VP confirmation, GlycanAge retail, and BTL EMSella SOP. Ladder runs from acute clinical (post-prostatectomy) to ongoing premium (Optimise+ + concierge).
| Tier | What's included | Price |
|---|---|---|
| Initial consultation | 30 min Gemma + history + IIEF-5 + IPSS + recommended next step | £99 |
| Men's EMSella course | 6× 28-min sessions over 3 weeks (general men's pelvic floor) | £495 |
| Post-prostatectomy programme | 12× EMSella + PSA monitoring service + Gemma reviews + UHDB pathway | £1,295 |
| Foundations (men's longevity) | Stride male panel + Tanita + 60-min Gemma + dashboard provisioning | £1,495 |
| Optimise (men's longevity) | + GlycanAge + methylation + 6 EMSella + 6 HBOT + quarterly reviews | £2,995 |
| Optimise+ (men's longevity) | + 24 HBOT + GLP-1 if appropriate + concierge access | £4,999 |
| Total Wellness Reset (6mo) | Foundations + 6mo GLP-1 + 6 EMSella + 4 Exion + Profhilo + 1 PRP | £6,995 |
| Total Transformation (12mo) | Optimise + GLP-1 + 12 EMSella + 12 Exion + Profhilo + injectables + PRP + HBOT | £14,995 |
| Premium Total (12mo) | Optimise+ + GLP-1 unlimited + EMSella unlimited + 4 Profhilo + 6 inj/filler + PRP + HBOT unlimited + concierge | £24,995-34,995 |
| 5-year prepay | Optimise+ at locked-in price × 5 yrs | £24,500 |
Regent Street Clinic Derby SUPERSCREEN sits at £2,995 — the local premium ceiling. Our Foundations £1,495 sits below them at the entry tier. Optimise £2,995 matches. Optimise+ £4,999 is positioned above. HUM2N Mayfair Foundation £905 / Transformation £1,995 are London comparators — we're priced above HUM2N's mid-tier. Echelon Platinum £14,000 / HOOKE £21-54k/yr are the unreachable London concierge tier. Defensible East Midlands premium-but-attainable position.
Built from Report 05 persona research. Three named profiles aligned to the three tiers. The wife is the initiator, the husband is the buyer.
Profile: 49, housebuilder/property developer, Derby. £4m turnover company. Slight middle-age spread, occasional knee pain. Wife mentions ED quietly. Reads Telegraph weekend, watches motorsport.
Trigger: Mate's heart attack at the golf club. Wife pushes him to "get checked".
What he buys: Foundations baseline. May upgrade to Optimise after 6 months if results impress.
Profile: 54, MD of a £6m engineering firm in Derbyshire. PMI through company. Trains 3×/week. Quietly anxious about ApoB after father's stroke at 67.
Trigger: Friend's annual private health check. Wants "more than a tickbox screen".
What he buys: Optimise + spouse on Women's Foundations = Director Couple Optimise £6,995 (saves £995). Tax-efficient via company.
Profile: 58, owner of a £9m logistics business. Successful PE exit on the table next year. Wants to "still be sharp at 70". Recovers slowly from late nights / training.
Trigger: Cooper Parry tax adviser mentions the BIK exemption. Plus wife's friend's husband is in the programme.
What he buys: 5-year prepay at £24,500 OR Premium Total Transformation £24,995. Becomes the lighthouse case.
From Reports 03 (warm channel network) + 04 (visibility) + 01 (Companies House extraction). Channel priority — warm beats cold. Patient referral and wife referral convert highest. Cold email is bottom of the list.
| Item | Cost to DGP | Sell price | Margin |
|---|---|---|---|
| Stride Bloods (home phlebotomy) | £239 | £349 | £110 |
| GlycanAge | £245 | £295 | £50 |
| TruDiagnostic methylation | £99 | £179 | £80 |
| Tanita scan + dashboard provisioning | ~£15 | included | — |
| EMSella 6 sessions (chair time + electricity) | ~£40 | included | ~£430 (vs separate purchase £495) |
| HBOT 6 sessions | ~£90 | included | ~£900 (vs separate £990) |
| Gemma 90-min consult + quarterly reviews | ~£200 | included | — |
| Total Optimise tier | ~£928 | £2,995 | £2,067 / 69% |
| Period | New baselines | EMSella courses | Optimise members | Optimise+ members | Annualised revenue (men's only) |
|---|---|---|---|---|---|
| Year 1 | 25-50 | 15-30 | 8-15 | 2-5 | £120-220k |
| Year 2 | 60-100 | 40-70 | 30-50 | 8-15 | £320-520k |
| Year 3 | 100-150 | 70-120 | 60-100 | 20-35 | £800k-1.5m |
Lead capture (events / Companies House / IoD speaker / Cooper Parry referrals) → Klaviyo nurture (5-email sequence) → 5-15% book £99 consult → 50% bloods upsell at consult → 15-30% to longevity tier within 90 days.
Per 100 captured leads: ~10-15 consults → ~5-8 bloods sold → ~2-4 baselines → ~0.5-1 longevity-tier conversion.
Pipeline value per 100 leads (mid): £3,500-£6,500. At 800 leads/year (mobile + warm channels + cold extraction combined) = £28-£52k of incremental revenue from the funnel alone.
If consult-to-Optimise runs at 2.5% instead of 5% (warm-channel mid case), revenue drops ~£40k Y1. Mitigation: track weekly; if Sep 2026 data shows <3%, restructure consults to be more diagnostic-led with clearer "we should run X test" recommendations.
One clinical director is a single point of failure. Solo capacity saturates around 80-100 active patients. Mitigation: hire second male-friendly GP by end of Y1. FSRH-Diploma + men's-health interest + part-time/locum pattern. £400-600/day contractor or £55-70k salaried.
ASA/CAP code prohibits naming Mounjaro / Wegovy / GLP-1 in B2C advertising. 5+ UK clinics censured Feb 2026. Mitigation: GLP-1 marketed B2B only via corporate channel, never B2C ads. Patient-facing materials reference "weight management consultation" not GLP-1 by name.
Regent Street Clinic Derby could expand from £2,995 SUPERSCREEN into longevity-tier subscription. Mitigation: lock the warm-channel partnerships (Cooper Parry exclusivity by relationship not contract). Build the Recovery Membership ARR base before they do.
If multiple brokers refer competing services, may dilute. Mitigation: structure rev-share so only top 2-3 brokers per tier are active. Avoid brokers who also refer to Regent Street Clinic.
~3,500 enriched prospects per 30-day cycle. Tooling stack £129/mo.
Defensible East Midlands premium-but-attainable band confirmed.
Cooper Parry, IoD, Mattioli Woods. Named contacts.
University of Derby Top 200 Businesses, Marketing Derby Bondholder, sponsorship costs.
Three personas. Wife-as-initiator. Position-against-PMI.
Mid-tier hard chamber, £85k capital, payback 7-8 months.
22% UK GLP-1 male share — the gap to own. B2B sidesteps ASA.
HMRC EIM21765 zero-BIK angle. £14,950-£24,950 packages.
Total Transformation tiers. CQC reform 2025-26 erases Derby competition.
Jockeys, motorsport drivers, multi-day race weekends.
Sourced costs, real funnel maths, sensitivity analysis.
The patient-facing version of the men's longevity proposition (Gemma's voice, dark premium aesthetic).